Phase II, two-stage, single-arm trial of the histone deacetylase inhibitor (HDACi) romidepsin in metastatic castration-resistant prostate cancer (CRPC)
Molife, L. R., Attard, G., Fong, P. C., Karavasilis, V., Reid, A. H. M., Patterson, S., Riggs, C. E., Higano, C., Stadler, W. M., McCulloch, W., Dearnaley, D., Parker, C., de Bono, J. S.
Published in Annals of oncology (01.01.2010)
Published in Annals of oncology (01.01.2010)
Get full text
Journal Article
Poly (ADP-ribose) polymerase (PARP) inhibitors for the treatment of advanced germline BRCA2 mutant prostate cancer
Sandhu, S.K., Omlin, A., Hylands, L., Miranda, S., Barber, L.J., Riisnaes, R., Reid, A.H., Attard, G., Chen, L., Kozarewa, I., Gevensleben, H., Campbell, J., Fenwick, K., Assiotis, I., Olmos, D., Yap, T.A., Fong, P., Tunariu, N., Koh, D., Molife, L.R., Kaye, S., Lord, C.J., Ashworth, A., de Bono, J.
Published in Annals of oncology (01.05.2013)
Published in Annals of oncology (01.05.2013)
Get full text
Journal Article
2759 Management of nausea and vomiting during treatment with the capsule (CAP) and tablet (TAB) formulations of the PARP inhibitor olaparib
Banerjee, S, Ledermann, J, Matulonis, U, Molife, L.R, Friedlander, M, Fielding, A, Robertson, J.D, Spencer, S, McMurtry, E, Kaye, S
Published in European journal of cancer (1990) (01.09.2015)
Published in European journal of cancer (1990) (01.09.2015)
Get full text
Journal Article
Olaparib monotherapy in patients with advanced relapsed ovarian cancer and a germline BRCA1/2 mutation: A multi-study sub-analysis
Penson, R.T, Domchek, S.M, Kaufman, B, Audeh, M.W, Kaye, S.B, Molife, L.R, Mann, H, Robertson, J, Coleman, R.L
Published in Gynecologic oncology (01.04.2015)
Published in Gynecologic oncology (01.04.2015)
Get full text
Journal Article
27LBA Evidence of activity of a new mechanism of action (MoA): A first-in-human study of the first-in-class fatty acid synthase (FASN) inhibitor, TVB-2640, as monotherapy or in combination
Arkenau, H.T, Voskoboynik, M, Infante, J, Brenner, A, Patel, M, Borazanci, E, Falchook, G, Molife, L.R, Pant, S, Dean, E, Pelosof, L, Jones, S, Rubino, C, McCulloch, W, Zhukova-Harrill, V, Kemble, G, O'Farrell, M, Burris, H
Published in European journal of cancer (1990) (01.09.2015)
Published in European journal of cancer (1990) (01.09.2015)
Get full text
Journal Article
343 Translational phase I trial combining the AKT inhibitor AZD5363 (AZD) and PARP inhibitor Olaparib (Ola) in advanced cancer patients (pts)
Michalarea, V, Lopez, J, Lorente, D, Carreira, S, Hassam, H, Parmar, M, Turner, A, Hall, E, Fandos, S. Serrano, Decordova, S, Swales, K, Ruddle, R, Raynaud, F, Tunariu, N, Stephens, C.M, Molife, L.R, Banerji, U, Plummer, R, Bono, J. De, Yap, T.A
Published in European journal of cancer (1990) (01.09.2015)
Published in European journal of cancer (1990) (01.09.2015)
Get full text
Journal Article
1202 ORAL A Phase I Study of the Potent AKT Inhibitor MK-2206 in Combination With Carboplatin and Paclitaxel, Docetaxel or Erlotinib in Patients With Advanced Solid Tumours
Molife, L.R, Minton, S, Vitfell-Pedersen, J, Chen, E, Sullivan, D, Yan, L, Zernhelt, A.M, Siu, L, de Bono, J.S, Tolcher, A.W
Published in European journal of cancer (1990) (2011)
Published in European journal of cancer (1990) (2011)
Get full text
Journal Article
405 A mass balance study to investigate the metabolism, excretion and pharmacokinetics of [14C]-olaparib (AZD2281) in patients with advanced solid tumours refractory to standard treatments
Ang, J.E, Clarkson-Jones, J.A, Swaisland, H, Brunetto, A.T, Lal, R, Farnsworth, A.P, Molife, L.R, Kaye, S.B, Carmichael, J, de Bono, J.S
Published in European journal of cancer supplements (2010)
Published in European journal of cancer supplements (2010)
Get full text
Journal Article
Olaparib monotherapy in patients with advanced relapsed ovarian cancer and a germline BRCA1/2 mutation: a multistudy analysis of response rates and safety
Matulonis, U.A., Penson, R.T., Domchek, S.M., Kaufman, B., Shapira-Frommer, R., Audeh, M.W., Kaye, S., Molife, L.R., Gelmon, K.A., Robertson, J.D., Mann, H., Ho, T.W., Coleman, R.L.
Published in Annals of oncology (01.06.2016)
Published in Annals of oncology (01.06.2016)
Get full text
Journal Article
669P Subsequent therapy following pembrolizumab + axitinib or sunitinib treatment for advanced renal cell carcinoma (RCC) in the phase III KEYNOTE-426 study
Gafanov, R., Powles, T.B., Bedke, J., Stus, V., Waddell, T.S., Nosov, D., Pouliot, F., Soulieres, D., Melichar, B., Azevedo, S., McDermott, R.S., Vynnychenko, I.O., Borchiellini, D., Markus, M., Bondarenko, I., Lin, J., Burgents, J., Molife, L.R., Plimack, E.R., Rini, B.
Published in Annals of oncology (01.09.2021)
Published in Annals of oncology (01.09.2021)
Get full text
Journal Article
Antitumor activity of ipatasertib combined with chemotherapy: results from a phase Ib study in solid tumors
Isakoff, S.J., Tabernero, J., Molife, L.R., Soria, J.-C., Cervantes, A., Vogelzang, N.J., Patel, M.R., Hussain, M., Baron, A., Argilés, G., Conkling, P.R., Sampath, D., Maslyar, D., Patel, P., Chan, W., Gendreau, S., Musib, L., Xu, N., Ma, H., Lin, K., Bendell, J.
Published in Annals of oncology (01.05.2020)
Published in Annals of oncology (01.05.2020)
Get full text
Journal Article
200O Pembrolizumab plus axitinib (pembro + axi) vs sunitinib in metastatic renal cell carcinoma (mRCC) outcomes of the KEYNOTE-426 study in patients from eastern Asia
Kondoh, C.N., Bae, W.K., Tamada, S., Matsubara, N., Lee, H.J., Mizuno, R., Ani, S., Kimura, G., Tomita, Y., Chang, C-H., Chang, J.W-C., Lin, J., Perini, R., Molife, L.R., Powles, T.B., Rini, B., Chung, H-J.
Published in Annals of oncology (01.11.2020)
Published in Annals of oncology (01.11.2020)
Get full text
Journal Article
A phase I dose escalation study of AT9283, a small molecule inhibitor of aurora kinases, in patients with advanced solid malignancies
Arkenau, H.-T., Plummer, R., Molife, L.R., Olmos, D., Yap, T.A., Squires, M., Lewis, S., Lock, V., Yule, M., Lyons, J., Calvert, H., Judson, I.
Published in Annals of oncology (01.05.2012)
Published in Annals of oncology (01.05.2012)
Get full text
Journal Article
Nivolumab in previously treated patients with metastatic squamous NSCLC: Results of a European single-arm, phase 2 trial (CheckMate 171) including patients aged ≥70 years and with poor performance status
Popat, S., Ardizzoni, A., Ciuleanu, T., Cobo Dols, M., Laktionov, K., Szilasi, M., Califano, R., Carcereny Costa, E., Griffiths, R., Paz-Ares, L., Szczylik, C., Corral, J., Isla, D., Jassem, J., Appel, W., Van Meerbeeck, J., Wolf, J., Jiang, J., Molife, L.R., Felip Font, E.
Published in Annals of oncology (01.09.2017)
Published in Annals of oncology (01.09.2017)
Get full text
Journal Article
Phase II study of eribulin mesylate (E7389) in patients with metastatic castration-resistant prostate cancer stratified by prior taxane therapy
de Bono, J.S., Molife, L.R., Sonpavde, G., Maroto, J.P., Calvo, E., Cartwright, T.H., Loesch, D.M., Feit, K., Das, A., Zang, E.A., Wanders, J., Agoulnik, S., Petrylak, D.P.
Published in Annals of oncology (01.05.2012)
Published in Annals of oncology (01.05.2012)
Get full text
Journal Article
Predictive Factors of Survival for Patients with Bladder Cancer (Bc) in Phase I Clinical Trials
Michalarea, V., Rafii, S., Kumar, R., Rihawi, K., Toloui, H.N., Huddart, R., Kaye, S.B., Banerji, U., de Bono, J.S., Molife, L.R.
Published in Annals of oncology (01.09.2014)
Published in Annals of oncology (01.09.2014)
Get full text
Journal Article
Clinical Outcome of Advanced Non-Small Cell Lung Cancer Patients (Ansclc Pts) on Phase I Trials in the Drug Development Unit (Ddu) at the Royal Marsden Hospital (Rmh)
Capelan, M., Roda, D., Geuna, E., Rihawi, K., Shankar, B., Kaye, S.B., Bhosle, J., Molife, L.R., Banerji, U., Óbrien, M., De Bono, J.S., Popat, S., Yap, T.A.
Published in Annals of oncology (01.09.2014)
Published in Annals of oncology (01.09.2014)
Get full text
Journal Article
1241PCLINICAL OUTCOME OF ADVANCED NON-SMALL CELL LUNG CANCER PATIENTS (ANSCLC PTS) ON PHASE I TRIALS IN THE DRUG DEVELOPMENT UNIT (DDU) AT THE ROYAL MARSDEN HOSPITAL (RMH)
Capelan, M., Roda, D., Geuna, E., Rihawi, K., Shankar, B., Kaye, S.B., Bhosle, J., Molife, L.R., Banerji, U., Óbrien, M., De Bono, J.S., Popat, S., Yap, T.A.
Published in Annals of oncology (01.09.2014)
Published in Annals of oncology (01.09.2014)
Get full text
Journal Article
863PPREDICTIVE FACTORS OF SURVIVAL FOR PATIENTS WITH BLADDER CANCER (BC) IN PHASE I CLINICAL TRIALS
Michalarea, V., Rafii, S., Kumar, R., Rihawi, K., Toloui, H.N., Huddart, R., Kaye, S.B., Banerji, U., de Bono, J.S., Molife, L.R.
Published in Annals of oncology (01.09.2014)
Published in Annals of oncology (01.09.2014)
Get full text
Journal Article
Abstract A54: First-in-human study of the first-in-class fatty acid synthase (FASN) inhibitor, TVB-2640 as monotherapy or in combination - final results of dose escalation
Brenner, Andrew, Infante, Jeffrey, Patel, Manish, Arkenau, Hendrik-Tobias, Voskoboynik, Mark, Borazanci, Erkut, Falchook, Gerald, Molife, L.R., Pant, Shubham, Dean, Emma, Pelosof, Lorraine, Jones, Suzanne, Rubino, Chris, McCulloch, William, Zhukova-Harrill, Valentina, Kemble, George, O'Farrell, Marie, Burris, Howard A.
Published in Molecular cancer therapeutics (01.12.2015)
Published in Molecular cancer therapeutics (01.12.2015)
Get full text
Journal Article